Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

INTRODUCTION: Different antivirals are available for the treatment of outpatients with COVID-19. Our aim was to describe a real-world experience of outpatient management of COVID-19 subjects at high risk of progression. METHODS: This prospective observational study conducted in the University Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiseo, Giusy, Barbieri, Chiara, Galfo, Valentina, Occhineri, Sara, Matucci, Tommaso, Almerigogna, Francesco, Kalo, Jona, Sponga, Pietro, Cesaretti, Mario, Marchetti, Gabriele, Forniti, Arianna, Caroselli, Claudio, Ferranti, Simone, Pogliaghi, Manuela, Polidori, Marina, Fabiani, Silvia, Verdenelli, Stefano, Tagliaferri, Enrico, Riccardi, Niccolò, Suardi, Lorenzo Roberto, Carmignani, Claudia, Batini, Serena, Puccetti, Luca, Iapoce, Riccardo, Menichetti, Francesco, Falcone, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707131/
https://www.ncbi.nlm.nih.gov/pubmed/36441485
http://dx.doi.org/10.1007/s40121-022-00729-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707131/
https://www.ncbi.nlm.nih.gov/pubmed/36441485
http://dx.doi.org/10.1007/s40121-022-00729-2

Ejemplares similares